Literature DB >> 25348881

Anti-TNF-α treatment for post-anastomotic ulcers and inflammatory bowel disease with Crohn's-like pathologic changes following intestinal surgery in pediatric patients.

Jennifer J Freeman1, Raja Rabah, Ronald B Hirschl, Aldo Maspons, Donald Meier, Daniel H Teitelbaum.   

Abstract

PURPOSE: To report a previously poorly recognized process of secondary formation of inflammatory bowel disease (IBD)-like process, specifically Crohn's-like changes in pediatric surgery patients who underwent major small bowel and colorectal surgery. We describe potential etiologies, presenting symptoms and treatment approaches.
METHODS: Retrospective chart review of patients with history of either chronic, partial gastrointestinal (GI) obstruction or Hirschsprung disease (HD) and subsequent histopathologic findings similar to IBD. Pathology and case histories were reviewed and treatments were compared.
RESULTS: Over the last 20 years, a total of nine patients were identified that had the diagnoses of either HD (n = 3) or chronic GI partial obstruction (n = 6) with subsequent development of histopathologic changes similar to those seen in IBD. Overall meantime to diagnosis of IBD-like changes after intestinal resection was 7.70 ± 5.6 years. Half of the patients were also being managed for short bowel syndrome (SBS), and associated GI symptoms may have prolonged the time to identifying these IBD-like changes. When SBS patients were excluded, mean time to IBD changes after pull through for HD was 2.4 ± 0.24 years and after chronic GI partial obstruction was 6.3 ± 2.1 years. Two of the nine patients who underwent a resection of this IBD-like lesion developed a recurrence of this lesion. Anti-TNF-α treatment was used in three of the GI partial obstruction cases: two with complete relief and one with partial response that was supplemented with steroids. Two HD patients were treated with anti-TNF-α and both had marked improvement of symptoms.
CONCLUSION: We describe IBD-like intestinal changes following intestinal resection in the pediatric age group. We also present the novel finding that these lesions are responsive to anti-IBD treatment, including anti-TNF-α, and recommend it as part of the medical treatment regiment offered for such patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25348881      PMCID: PMC4824052          DOI: 10.1007/s00383-014-3633-4

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  10 in total

1.  Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.

Authors:  Amit H Sachdev; Mark Pimentel
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

2.  Has smoking changed the epidemiology of ulcerative colitis?

Authors:  C Tysk; G Järnerot
Journal:  Scand J Gastroenterol       Date:  1992-06       Impact factor: 2.423

Review 3.  Quality improvement in pediatric inflammatory bowel disease: moving forward to improve outcomes.

Authors:  Pauline Quach; Geoffrey C Nguyen; Eric I Benchimol
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 4.  Ileocolonic anastomotic ulcers: a case series and review of the literature.

Authors:  S T Chari; R F Keate
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

5.  Inflammatory bowel disease manifesting after surgical treatment for Hirschsprung disease.

Authors:  David N Levin; Margaret A Marcon; Risto J Rintala; Dustin Jacobson; Jacob C Langer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

Review 6.  Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome.

Authors:  Dan Knights; Kara G Lassen; Ramnik J Xavier
Journal:  Gut       Date:  2013-10       Impact factor: 23.059

7.  Anastomotic ulceration: a late complication of ileocolonic anastomosis.

Authors:  J M Sondheimer; R J Sokol; M R Narkewicz; R W Tyson
Journal:  J Pediatr       Date:  1995-08       Impact factor: 4.406

Review 8.  Update in pediatric inflammatory bowel disease.

Authors:  Shervin Rabizadeh; Marla Dubinsky
Journal:  Rheum Dis Clin North Am       Date:  2013-07-17       Impact factor: 2.670

Review 9.  Gut microbiota in inflammatory bowel disease.

Authors:  Jung Ok Shim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-03-31

10.  Pre-diagnostic Clinical Presentations and Medical History Prior to the Diagnosis of Inflammatory Bowel Disease in Children.

Authors:  Yong Hoon Kwon; Yong Joo Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-09-30
  10 in total
  4 in total

Review 1.  Pediatric short bowel syndrome and subsequent development of inflammatory bowel disease: an illustrative case and literature review.

Authors:  Katherine J Baxter; Jahnavi K Srinivasan; Thomas R Ziegler; Tanvi Dhere; Richard R Ricketts; Megan M Durham
Journal:  Pediatr Surg Int       Date:  2017-04-04       Impact factor: 1.827

Review 2.  Inflammatory bowel disease in patients with Hirschsprung's disease: a systematic review and meta-analysis.

Authors:  H Nakamura; T Lim; P Puri
Journal:  Pediatr Surg Int       Date:  2017-10-05       Impact factor: 1.827

3.  Characterization of Bacterial and Fungal Microbiome in Children with Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study.

Authors:  Philip K Frykman; Agneta Nordenskjöld; Akemi Kawaguchi; Thomas T Hui; Anna L Granström; Zhi Cheng; Jie Tang; David M Underhill; Iliyan Iliev; Vince A Funari; Tomas Wester
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

4.  Anti-inflammatory effects of Fagopyrum cymosum administered as a potential drug for ulcerative colitis.

Authors:  Fei Ge; Shilin Zhu; Lina Liu; Jing Yan; Yu Ji; Zhiguang Sun
Journal:  Exp Ther Med       Date:  2017-09-20       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.